The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Side effects

Dizziness on standing and the electrolyte explanation — does this still hold?

Solved
Solved by taper_shift in post #8
Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency.

Jump to the accepted answer →

LC
l.cabreraTL2 Moderator8 Sep 2025#1

The question in the title: Dizziness on standing and the electrolyte explanation — does this still hold? I will give what I have already checked below so nobody repeats it.

I have read the maintained page on this and I still have a gap, so I am asking rather than guessing.

Context: tirzepatide, 11 weeks in, currently at a dose I reached by the standard four-week steps. Everything below is my own record rather than anything a clinician told me.

The specific question is the one in the title. What I have already checked: the labelling summary on the relevant documentation page, the two most-linked topics in this subcategory, and my own notes from the last 11 weeks. What I could not find is whether the answer changes at higher doses or whether it is the same arithmetic throughout.

If the answer is "it depends", I would rather know what it depends on than be given a number.

0 likes 11mo
F
FFaulknerTL3Regular17 Sep 2025#2

Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious complication. Distinguishing ordinary gastrointestinal effects from the rare severe end is a clinical judgement.

19 likes 10mo
VO
v.okonkwoTL2 Moderator22 Sep 2025#3

Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears.

8 likes 10mo
O
OFalkenbergTL1Member28 Sep 2025#4

post #3 answers the question as asked. The question underneath it is different.

Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid.

2 likes 10mo
FC
f.chowdhuryTL2 Moderator2 Oct 2025 · edited#5
v.okonkwo, post #3: Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears. Go to post

I read post #3 twice before replying, because I had assumed the opposite.

Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training intensity both help preserve lean mass during weight reduction.

27 likes in reply to #3 10mo
O
OstrowskiTL2Member7 Oct 2025#6
v.okonkwo, post #3: Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears. Go to post

Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound specifically. It is usually self-limiting.

13 likes in reply to #3 10mo
HN
h.nwosuTL2 Moderator11 Oct 2025#7

Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before attributing all of it to the compound. Some fatigue resolves with time; some persists.

4 likes 10mo
TS
taper_shiftTL3Regular Solution16 Oct 2025#8

Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency.

7 likes 9mo
MA
m.amankwahTL2 Moderator20 Oct 2025#9
OFalkenberg, post #4: post #3 answers the question as asked. The question underneath it is different. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid. Go to post

Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you track whether something is worsening or stable and helps your clinician understand what you are reporting.

0 likes in reply to #4 9mo
SC
sourced_claimsTL3Regular24 Oct 2025#10

Picking up post #7: that is the part I would want checked first.

Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting those details gets better responses than reporting the symptom alone.

0 likes 9mo
SF
sterile_fileTL328 Oct 2025#11
NC
n.chowdhuryTL2 Moderator31 Oct 2025#12

Coming back to post #10, because the follow-up matters more than the original answer.

Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is usually effective. This is worth addressing proactively rather than waiting for it to worsen.

20 likes 9mo
F
FairweatherTL2Member4 Nov 2025#13

Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during titration is ordinary. Persistent vomiting or vomiting of a new character later in treatment warrants contact with your clinician.

0 likes 9mo
KB
ka.batistaTL2 Moderator8 Nov 2025#14

Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training intensity both help preserve lean mass during weight reduction.

0 likes 9mo
B
BDraganovTL2Member11 Nov 2025#15
h.nwosu, post #7: Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before attributing all of it to the compound. Some fatigue resolves with time; some persists. Go to post

This follows post #12 rather than contradicting it.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

5 likes in reply to #7 8mo
HK
h.kimaniTL2 Moderator15 Nov 2025#16
sterile_file, post #11: Picking up post #8: that is the part I would want checked first. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and attenuates as the dose is held stable. At each escalation step it often resets briefly before attenuating again. Go to post

Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and attenuates as the dose is held stable. At each escalation step it often resets briefly before attenuating again.

14 likes in reply to #11 8mo
HA
h.almeidaTL2Member18 Nov 2025#17

Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is usually effective. This is worth addressing proactively rather than waiting for it to worsen.

29 likes 8mo
JP
j.palaciosTL2 Moderator22 Nov 2025 · edited#18

Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during titration is ordinary. Persistent vomiting or vomiting of a new character later in treatment warrants contact with your clinician.

0 likes 8mo
TK
t.kulkarniTL3Regular25 Nov 2025 · edited#19

Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting those details gets better responses than reporting the symptom alone.

2 likes 8mo
GO
g.oyelaranTL2 Moderator29 Nov 2025#20
h.kimani, post #16: Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and attenuates as the dose is held stable. At each escalation step it often resets briefly before attenuating again. Go to post

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

9 likes in reply to #16 8mo
TM
t.marchettiTL2 Moderator2 Dec 2025 · edited#21

Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears.

25 likes 8mo
I
IHollingworthTL2Member5 Dec 2025#22
g.oyelaran, post #20: Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had been repeating something I had not checked carefully enough. Go to post

Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid.

11 likes in reply to #20 8mo
NR
n.ramosTL2 Moderator9 Dec 2025#23

On post #19 — agreed on the reasoning, with one qualification.

Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you track whether something is worsening or stable and helps your clinician understand what you are reporting.

1 like 8mo
EA
e.almeidaTL2Member12 Dec 2025#24

post #23 answers the question as asked. The question underneath it is different.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

0 likes 8mo
AW
ai.wikstromTL2 Moderator15 Dec 2025#25

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

33 likes 7mo
P
PWendelboeTL118 Dec 2025#26
CN
c.nybergTL2 Moderator21 Dec 2025#27
IHollingworth, post #22: Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid. Go to post

Worth separating two things that post #23 runs together.

Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before attributing all of it to the compound. Some fatigue resolves with time; some persists.

3 likes in reply to #22 7mo
LS
l.sarkissianTL2Member24 Dec 2025#28

Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound specifically. It is usually self-limiting.

0 likes 7mo
HB
h.brandtTL2 Moderator27 Dec 2025#29

Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious complication. Distinguishing ordinary gastrointestinal effects from the rare severe end is a clinical judgement.

0 likes 7mo
RV
r.venkatesanTL3Wiki editor30 Dec 2025#30

Picking up post #27: that is the part I would want checked first.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

24 likes 7mo